Serogen Warnings

Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorder in these neonates. These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization. Serogen should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Elderly patients with dementia-related psychosis treated with antipsychoyic drugs are at an increased risk of death. Quetiapine is not approved for elderly patients with dementia-related psychosis.